Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure: Eight-year experience with the implantable HeartMate LVAS.
Authors:
- J R LahporJLJ R Lahpor
- N De JongeNJN De Jonge
- H A Van SwietenHSH A Van Swieten
- H WesenhagenHWH Wesenhagen
- C KlöppingCKC Klöpping
- J H GeertmanJGJ H Geertman
- A OosteromAOA Oosterom
- B RodermansBRB Rodermans
- J H KirkelsJKJ H Kirkels
- 1 June 2002
- journal article
- Vol. 10 (6) , 267-271
Abstract
To evaluate the use of left ventricular assist devices (LVAD) as bridge to heart transplantation (HTx) in patients with end-stage heart failure. Between March 1993 and December 2001, 38 patients with refractory end-stage heart failure underwent HeartMate LVAD (Thoratec, Pleasanton Calif.) implantation. A total of 33 of the 38 patients (87%) survived the implantation and perioperative period. There were five perioperative deaths (13%), two due to right ventricular failure, two as a result of bleeding and one probably due to septic shock at the time of LVAD implantation. Three patients (9%) died late in the postoperative period due to septic shock, mechanical failure of the device and a cerebral embolus resulting from LVAD endocarditis, initiated by an acute cholecystitis. Twelve patients (32%) had one or more infectious episodes during long-term assist, of which one patient died. Four patients are still on the device, waiting for a heart transplantation. Twenty-six patients (76%) underwent HTx after 206±129 days of support. These results show the efficacy of LVAD support as a bridge to heart transplantation in patients with end-stage heart failure. Major long-term complications are infections and mechanical failure of the device.Keywords
This publication has 14 references indexed in Scilit:
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantationJACC, 2001
- Novacor left ventricular assist system versus heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: A prospective studyThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertionThe Annals of Thoracic Surgery, 1999
- Implantable Left Ventricular Assist DevicesNew England Journal of Medicine, 1998
- Perinatal HIV-1 transmission discussed in GenevaThe Lancet, 1998
- One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technologyThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994The Annals of Thoracic Surgery, 1996
- Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist deviceThe Annals of Thoracic Surgery, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991